Cargando…

Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response

BACKGROUND: Silicosis is an important occupational disease caused by inhalation of free silica and is characterized by persistent pulmonary inflammation, subsequent fibrosis and lung dysfunction. Until now, there has been no effective treatment for the disease due to the complexity of pathogenesis....

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Shuangshuang, Yang, Zhifeng, Zhang, Xiaofeng, Li, Ming, Han, Na, Yang, Xiaohan, He, Jin, Yu, Gongchang, Meng, Xiangjing, Jia, Qiang, Shao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571334/
https://www.ncbi.nlm.nih.gov/pubmed/37828528
http://dx.doi.org/10.1186/s13020-023-00823-8
_version_ 1785119966680317952
author Pu, Shuangshuang
Yang, Zhifeng
Zhang, Xiaofeng
Li, Ming
Han, Na
Yang, Xiaohan
He, Jin
Yu, Gongchang
Meng, Xiangjing
Jia, Qiang
Shao, Hua
author_facet Pu, Shuangshuang
Yang, Zhifeng
Zhang, Xiaofeng
Li, Ming
Han, Na
Yang, Xiaohan
He, Jin
Yu, Gongchang
Meng, Xiangjing
Jia, Qiang
Shao, Hua
author_sort Pu, Shuangshuang
collection PubMed
description BACKGROUND: Silicosis is an important occupational disease caused by inhalation of free silica and is characterized by persistent pulmonary inflammation, subsequent fibrosis and lung dysfunction. Until now, there has been no effective treatment for the disease due to the complexity of pathogenesis. Fermented cordyceps powder (FCP) has a similar effect to natural cordyceps in tonifying the lung and kidney. It has started to be used in the adjuvant treatment of silicosis. This work aimed to verify the protective effects of FCP against silicosis, and to explore the related mechanism. METHODS: Wistar rats were randomly divided into four groups including the saline-instilled group, the silica-exposed group, the silica + FCP (300 mg/kg) group and the silica + FCP (600 mg/kg) group. Silicosis rat models were constructed by intratracheal instillation of silica (50 mg). Rats in the FCP intervention groups received the corresponding dose of FCP daily by intragastric gavage. Rats were sacrificed on days 7, 28 and 56 after treatment, then samples were collected for further analysis. RESULTS: FCP intervention reduced the infiltration of inflammatory cells and the concentration of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1) at days 7, 28, 56, and decreased the expression of collagen, α-smooth muscle actin (α-SMA) and fibronectin (FN) at days 28 and 56 in the lung of silicosis rats. FCP also decreased the immune response of Th1 and Th17 at days 7, 28, 56 and inhibited the enhancement of the Th2 response at day 56. CONCLUSIONS: FCP intervention could alleviate silica-induced pulmonary inflammation and fibrosis, the protective effect may be achieved by reducing Th1 and Th17 immune responses and inhibiting the enhancement of the Th2 response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-023-00823-8.
format Online
Article
Text
id pubmed-10571334
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105713342023-10-14 Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response Pu, Shuangshuang Yang, Zhifeng Zhang, Xiaofeng Li, Ming Han, Na Yang, Xiaohan He, Jin Yu, Gongchang Meng, Xiangjing Jia, Qiang Shao, Hua Chin Med Research BACKGROUND: Silicosis is an important occupational disease caused by inhalation of free silica and is characterized by persistent pulmonary inflammation, subsequent fibrosis and lung dysfunction. Until now, there has been no effective treatment for the disease due to the complexity of pathogenesis. Fermented cordyceps powder (FCP) has a similar effect to natural cordyceps in tonifying the lung and kidney. It has started to be used in the adjuvant treatment of silicosis. This work aimed to verify the protective effects of FCP against silicosis, and to explore the related mechanism. METHODS: Wistar rats were randomly divided into four groups including the saline-instilled group, the silica-exposed group, the silica + FCP (300 mg/kg) group and the silica + FCP (600 mg/kg) group. Silicosis rat models were constructed by intratracheal instillation of silica (50 mg). Rats in the FCP intervention groups received the corresponding dose of FCP daily by intragastric gavage. Rats were sacrificed on days 7, 28 and 56 after treatment, then samples were collected for further analysis. RESULTS: FCP intervention reduced the infiltration of inflammatory cells and the concentration of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1) at days 7, 28, 56, and decreased the expression of collagen, α-smooth muscle actin (α-SMA) and fibronectin (FN) at days 28 and 56 in the lung of silicosis rats. FCP also decreased the immune response of Th1 and Th17 at days 7, 28, 56 and inhibited the enhancement of the Th2 response at day 56. CONCLUSIONS: FCP intervention could alleviate silica-induced pulmonary inflammation and fibrosis, the protective effect may be achieved by reducing Th1 and Th17 immune responses and inhibiting the enhancement of the Th2 response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-023-00823-8. BioMed Central 2023-10-12 /pmc/articles/PMC10571334/ /pubmed/37828528 http://dx.doi.org/10.1186/s13020-023-00823-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pu, Shuangshuang
Yang, Zhifeng
Zhang, Xiaofeng
Li, Ming
Han, Na
Yang, Xiaohan
He, Jin
Yu, Gongchang
Meng, Xiangjing
Jia, Qiang
Shao, Hua
Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response
title Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response
title_full Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response
title_fullStr Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response
title_full_unstemmed Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response
title_short Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response
title_sort fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the th immune response
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571334/
https://www.ncbi.nlm.nih.gov/pubmed/37828528
http://dx.doi.org/10.1186/s13020-023-00823-8
work_keys_str_mv AT pushuangshuang fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT yangzhifeng fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT zhangxiaofeng fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT liming fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT hanna fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT yangxiaohan fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT hejin fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT yugongchang fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT mengxiangjing fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT jiaqiang fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse
AT shaohua fermentedcordycepspowderalleviatessilicainducedpulmonaryinflammationandfibrosisinratsbyregulatingthethimmuneresponse